Literature DB >> 15458761

Medical marijuana: emerging applications for the management of neurologic disorders.

Gregory T Carter1, Vivian Ugalde.   

Abstract

Marijuana contains over 60 different types of cannabinoids, which are its medicinally active ingredients. Cannabinoids have the capacity for neuromodulation--through direct, receptor-based mechanisms--at many levels within the nervous system, providing therapeutic properties that may be applicable to the treatment of neurologic disorders. These include antioxidation, neuroprotection, analgesia, anti-inflammation, immunomodulation, modulation of glial cells, and tumor growth regulation. This article reviews the current and emerging research on the physiologic mechanisms of endogenous and exogenous cannabinoids and their applications in the management of neurologic disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15458761     DOI: 10.1016/j.pmr.2004.03.005

Source DB:  PubMed          Journal:  Phys Med Rehabil Clin N Am        ISSN: 1047-9651            Impact factor:   1.784


  5 in total

Review 1.  Blurred boundaries: the therapeutics and politics of medical marijuana.

Authors:  J Michael Bostwick
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

2.  Crohn's disease or abdominal tuberculosis?

Authors: 
Journal:  Gut       Date:  2007-12       Impact factor: 23.059

3.  Dosing medical marijuana: rational guidelines on trial in Washington State.

Authors:  Sunil K Aggarwal; Muraco Kyashna-Tocha; Gregory T Carter
Journal:  MedGenMed       Date:  2007-09-11

4.  Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis.

Authors:  Susanne A Wolf; Anika Bick-Sander; Klaus Fabel; Perla Leal-Galicia; Svantje Tauber; Gerardo Ramirez-Rodriguez; Anke Müller; Andre Melnik; Tim P Waltinger; Oliver Ullrich; Gerd Kempermann
Journal:  Cell Commun Signal       Date:  2010-06-17       Impact factor: 5.712

5.  Charcot-Marie-Tooth disease.

Authors:  Gregory T Carter; Michael D Weiss; Jay J Han; Phillip F Chance; John D England
Journal:  Curr Treat Options Neurol       Date:  2008-03       Impact factor: 3.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.